Valiant Laboratories, a company in the Pharmaceuticals industry, reported revenue of ₹117 crore and net profit of ₹0.41 crore for the September 2026 quarter.
Valiant Laboratories (NSE: VALIANTLAB-BE) closed at ₹94.91 on 20 Nov 2026, up 23.3% over the past year. Its market capitalisation is ₹515 crore and it trades at 31.8 times earnings.
Incorporated in 1980, Valiant Laboratories Ltd manufactures and deals in Pharmaceuticals and speciality chemicals
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.